First Time Loading...

Cerevel Therapeutics Holdings Inc
NASDAQ:CERE

Watchlist Manager
Cerevel Therapeutics Holdings Inc Logo
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Watchlist
Price: 42.63 USD -0.19% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

CERE Price Targets Summary
Cerevel Therapeutics Holdings Inc

Wall Street analysts forecast CERE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CERE is 44.27 USD with a low forecast of 31.31 USD and a high forecast of 47.25 USD.

CERE Lowest Forecast
Wall Street Target
31.31 USD
27% Downside
CERE Average Forecast
Wall Street Target
44.27 USD
4% Upside
CERE Highest Forecast
Wall Street Target
47.25 USD
11% Upside
Lowest
Price Target
31.31 USD
27% Downside
Average
Price Target
44.27 USD
4% Upside
Highest
Price Target
47.25 USD
11% Upside
Cerevel Therapeutics Holdings Inc Competitors:
Price Targets
300653
Yantai Zhenghai Bio-Tech Co Ltd
41% Upside
GBIO
Generation Bio Co
163% Upside
KMDA
Kamada Ltd
128% Upside
BONEX
Bonesupport Holding AB
24% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
41% Upside
GBIO
Generation Bio Co
163% Upside
KMDA
Kamada Ltd
128% Upside
BONEX
Bonesupport Holding AB
24% Upside
ZEAL
Zealand Pharma A/S
22% Upside
2256
Abbisko Cayman Ltd
163% Upside
EXAS
Exact Sciences Corp
54% Upside
ICCC
ImmuCell Corp
180% Upside

Revenue
Forecast

Revenue Estimate
Cerevel Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cerevel Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cerevel Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

See Also

Summary
CERE intrinsic value, competitors valuation, and company profile.
DCF Valuation
CERE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CERE stock valuation using valuation multiples.
Wall Street Estimates
CERE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CERE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CERE's stock price target?
Price Target
44.27 USD

According to Wall Street analysts, the average 1-year price target for CERE is 44.27 USD with a low forecast of 31.31 USD and a high forecast of 47.25 USD.

ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.